These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15203931)

  • 1. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
    Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
    J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Aug; 7(8):1035-43. PubMed ID: 15756712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-modified dry powder formulations for pulmonary gene delivery.
    Li HY; Birchall J
    Pharm Res; 2006 May; 23(5):941-50. PubMed ID: 16715384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
    Seville PC; Kellaway IW; Birchall JC
    J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes.
    Colonna C; Conti B; Genta I; Alpar OH
    Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
    Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
    Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z; Wang H; Vehring R
    Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
    Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.
    Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK
    Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin.
    Barazesh A; Gilani K; Rouini M; Barghi MA
    Daru; 2020 Jun; 28(1):75-85. PubMed ID: 31808069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.
    Chang RY; Wong J; Mathai A; Morales S; Kutter E; Britton W; Li J; Chan HK
    Eur J Pharm Biopharm; 2017 Dec; 121():1-13. PubMed ID: 28890220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.